Cargando...

Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid

Immunotherapy of murine autoimmune and allergic diseases by administration of peptides corresponding to the dominant T cell epitope is a reality. However, problems remain in applying this therapy to reduce antibody responses in humans. To overcome these difficulties, a preclinical system was develop...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Jackson, D J, Elson, C J, Kumpel, B M
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Science Inc 2004
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1809104/
https://ncbi.nlm.nih.gov/pubmed/15270840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2004.02521.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!